載入...
Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen Candida albicans
While the folate biosynthetic pathway has provided a rich source of antibacterial, antiprotozoal, and anticancer therapies, it has not yet been exploited to develop uniquely antifungal agents. Although there have been attempts to develop fungal-specific inhibitors of dihydrofolate reductase (DHFR),...
Na minha lista:
| 發表在: | mSphere |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316490/ https://ncbi.nlm.nih.gov/pubmed/32581079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00374-20 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|